© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
About N/A of shares are held by financial institutions. COPPELL ADVISORY SOLUTIONS LLC is the top corporate investor, holding 149 shares valued at $52.00. A 0% stake in Alterity Therapeutics Limited is owned by the company. owns - shares valued at -, which translates its holding of N/A of the stake in the company.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ATHE shares is N/A, representing N/A of the company's common stock.
N/A, in the last quarter, reduced its stake in ATHE by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the ATHE shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned ATHE shares holding by N/A last quarter which brought its holding to - shares worth -.
As per its latest 13F filing, COPPELL ADVISORY SOLUTIONS LLC increased its stake in ATHE by 100% in the last quarter. The institutional holder raised its holding to 149 shares having worth more than $52.00. N/A also added N/A more shares of ATHE to its portfolio, raising its holding to - shares of worth -. N/A also increased its ATHE shares holding by N/A which brought its holding to - shares worth -.
The insider with the most stakes in ATHE is N/A , N/A at the company. Additionally, ATHE stock is highly held by N/A N/A and N/A N/A among others.
Company executives, directors, and other insiders own N/A percent of Alterity Therapeutics Limited's stock. Within the last six months, there have been 0 transaction(s) in which ATHE insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .
There have been 0 transaction(s) during the past 6-months in which Alterity Therapeutics Limited insiders have bought stock, totalling 0 shares
Around 0 Alterity Therapeutics Limited shares are held by insiders, which represents about N/A of ATHE stock.
ATHE N/A, N/A holds the largest portfolio of the company's shares. ATHE shares owned by N/A total nearly -.
COPPELL ADVISORY SOLUTIONS LLC is the largest institutional owner in ATHE which holds 149 shares worth $52.00 or 0% of the total ATHE shares outstanding followed by N/A with ownership of - shares representing N/A of the ATHE ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ATHE is concerned, it is a stock which is not optionable.
Number of ATHE shares short is 84.25K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 8.74M shares of ATHE are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ATHE has 3.70B shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ATHE is 1.04.